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In this article, we present the development and psychometric properties of the
Multidimensional Assessment of COVID-19–Related Fears (MAC-RF). The MAC-RF is
an eight-item, self-report scale that has been developed to assess clinically relevant
domains of fear during the COVID-19 pandemic. The MAC-RF is based on a
comprehensive theoretical model conceptualizing fears during the pandemics as
resulting from an interaction of bodily, interpersonal, cognitive, and behavioral
experiences. The MAC-RF was administered to a sample of 623 Italian adults from the
community aged between 18 and 76 years old (M= 35.67, SD= 12.93), along with a
measure of current clinical symptoms. Item response theory analyses demonstrated that
each item of the MAC-RF provided sufficient information about the underlying construct of
fear. The statistical fit of the scale was satisfactory. MAC-RF total scores correlated
significantly and positively with total scores on the measure of psychopathology and with
the clinical symptom domain scores. A ROC (receiver operating characteristic) curve
analysis showed that the MAC-RF total score was sufficiently able to identify cases with
high levels of current psychopathology, with an area under the curve of.76. These findings
suggest that the MAC-RF can be used to assess pathological fear during pandemics. The
English, Italian, and French versions of the MAC-RF are annexed to this article for use by
clinicians and health services.
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Fear is an unpleasant emotion caused by the perception of threat,
which relates to danger, harm, or pain. This emotion stems from
subcortical and cortical interactions that especially involve the
“affective network” system of the brain (1), which includes the
amygdala, orbitofrontal cortex, temporal cortex, pallidum, and
insular cortex, among other structures. The amygdala and the
thalamic pathways are responsible for the automatic and rapid
appraisal of threat, whereas the hippocampus and the cortical
pathways provide more detailed information on the specific
context and characteristics of the threatening stimuli (2). Thus,
activation of the amygdala by threatening stimuli is cognitively
processed by the prefrontal and orbitofrontal cortex, leading to
an experience of fear.
Fear emerged during brain evolution to allow animals to cope
with dangers, e.g., by escaping or freezing (3), and it is usually
activated by potentially dangerous external stimuli that evoke
stress responses modulated by the hypothalamic-pituitary-adrenal
(HPA) axis and glucocorticoid hormones. The relationship
between fear and stress is complex and although both are often
experienced concurrently, stress is assumed to be broader and
usually encompassing fear. Therefore, stress responses do not
always entail fear, while acute fear typically occurs as a stress
response (4).
High levels of fear in humans represent a threat to the sense of
safety and security, which elicit further negative emotions and
generate alterations in physiological arousal and reactivity (5),
distress, and heightened anxiety sensitivity (6). These alterations
increase the risk of emotion dysregulation (7) and consequently,
the risk of psychopathology (8). In fact, intense experiences of
fear, especially when prolonged in time, may alter the regulation
of genes controlling the neuroendocrine response to stress (e.g.,
by an excessive synthesis and secretion of glucocorticoids) (9),
fostering physical and mental diseases (10).
Notably, fear experiences are common during a pandemic.
Pandemics are unique in terms of causing prominent fear
responses because the infection is transmitted invisibly, rapidly
and with an increased risk of mortality (11). This limits the capacity
of individuals to use adequate emotion regulation strategies (e.g.,
positive reappraisal of the situation) for coping with the situation,
which has often been the case during the COVID-19 pandemic. It
has been suggested that the pandemic has generated intense fear
experiences among many individuals (12), that an adequate
screening of these fears is necessary (13, 14) and that in some
cases psychological interventions are needed (15). Therefore,
understanding fears in the context of the COVID-19 pandemic is
important, using both a theoretical model and a valid measure that
would assess the fears and test the model.
The “Four Horsemen” of Fear
Schimmenti, Billieux, and Starcevic (12) proposed a theoretical
framework to account for fear experiences during the COVID-19
pandemic. They argued that a pandemic might generate fears
that involve main psychological means of grasping the reality.Frontiers in Psychiatry | www.frontiersin.org 2Accordingly, bodily, relational, cognitive, and behavioral
domains are involved in fear experiences during a pandemic,
with these four domains of fear being interrelated. Furthermore,
the model proposes that the four domains of fear are not
structured in a hierarchical manner, and that instead, they are
organized around a dialectical structure: the bodily domain
involves a) fear of the body and b) fear for the body; the
interpersonal domain involves c) fear of others and d) fear for
others; the cognitive domain involves e) fear of knowing and f)
fear of not knowing; the behavioral domain involves g) fear of
action and h) fear of inaction. Table 1 summarizes the types,
characteristics and domains of fear experience according to
Schimmenti et al.’s (12) theoretical model.
This theoretical model of fear experiences might contribute to
our understanding of the origin and maintenance of fear-related
symptoms during the COVID-19 pandemic. Based on the
described theoretical framework, we developed a brief
instrument, the Multidimensional Assessment of COVID-19-
Related Fears (MAC-RF). The name of the measure reflects the
fact that it is aimed to assess the four dimensions of fear
described in the theoretical model.
The MAC-RF could be used for several purposes. First, the
MAC-RF could serve as a screening instrument for clinically
significant fears, which would indicate a need for a thorough
clinical assessment if screening positive. Second, the MAC-RF
could be used to identify the specific fear experiences that would
help tailor preventive and treatment approaches. Third, this tool
could serve the purpose of monitoring changes in the level of fear
over time and measuring treatment response. This article aims to
present the development and preliminary psychometric
properties of the MAC-RF.TABLE 1 | Fear experiences during the coronavirus pandemic.
Types of fear
experience
Characteristics of fear experience Fear
domains
Fear of the body Sense of one’s physical vulnerability due to
which the body is perceived as a potential
source of danger.
Bodily
domain
Fear for the body Notion that one’s body needs to be
protected.
Fear of others Threat originates from contacts with other
persons, including key attachment figures,
because of the possibility of being infected.
Interpersonal
domain
Fear for others Threat concerns one’s contacts with other
people, including the loved ones, because
of the possibility of infecting them.
Fear of knowing Avoidance of information about the
pandemic as a way of reducing the effect of
the perceived threat.
Cognitive
domain
Fear of not knowing Coping with negative feelings by collecting
all information about the pandemic.
Fear of action Indecisiveness about taking action and a
sense of being paralyzed by uncertainty.
Behavioral
domain
Fear of inaction Inner pressure to take action and do
anything to avoid negative feelings and
thinking about the pandemic.July 2020 | Volume 11 | Article 748
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Development of the Scale
Before starting the study, we first established the quality criteria
for assessing the adequacy of the MAC-RF as follows:
a. The measure should assess all eight facets of fear identified in
Schimmenti et al.’s (12) theoretical model;
b. The measure should be brief, easy to administer and easy to
score to facilitate its use in health and community services,
i.e., only one item for each of the eight fear facets should be
retained;
c. The measure should have satisfactory psychometric properties
in terms of internal structure and convergent and predictive
validity (i.e., the scale should be positively, significantly, and at
least moderately correlated with an independent measure of
psychopathology and it should be able to identify individuals
with clinically significant fear experiences associated with
psychopathology).
In order to develop a measure that would be consistent with
the quality criterion (a), the first author developed an original
pool of 16 items to correspond to each facet of fear (two items for
each type of fear experience described in Table 1). Each item was
scored on a 5-point Likert scale (from 0 = very unlike me to 4 =
very like me), with higher scores on each item indicating higher
levels of the corresponding fear facet. The wording of all 16 items
was discussed with members of the research team and it was
iteratively modified until consensus was reached on face validity
of each item. It was then decided that an instrument with all 16
items would be administered in the validation study, with its final
version including only a single item for each facet of fear, in
accordance with the quality criterion (b).
Participants
Participants in this study were 623 Italian community-dwelling
adults (448 females, 71.9%) recruited online, ranging in age from
18 to 76 years (M= 35.67, SD= 12.93). Participants had 16.52
years of education on average (SD= 3.18). Their employment
status was as follows: employed (n=231, 37.1%), self-employed
(n=149, 23.9%), full-time students (n=151, 24.2%), homemakers
(n=20, 3.2%) and unemployed (n=72, 11.6%). Only 9% of
participants (n=56) lived alone and 8.7% (n=54) lived with
friends, whereas the majority lived with their partner and
offspring (n= 265, 42.5%) or with parents (n= 248, 39.8%). At
the time of the survey completion, the mean duration of
pandemic-related restrictions, such as lockdown, self-isolation,
or quarantine, was 48.82 days (SD=12.47).
Procedure
The study received an approval from the institutional review board
for psychological research of the first author’s university (code UKE-
IRBPSY-04.20.04). Participation was anonymous and voluntary and
participants received no compensation for completing the survey.
Participants were recruited by advertisements placed on social media
platforms, with a request for the survey to be disseminated via
respondents’ social media platforms. Participants signed anFrontiers in Psychiatry | www.frontiersin.org 3electronic informed consent before being directed to an online
survey, which consisted of a sociodemographic questionnaire, the
pool of 16 items developed by the research team to assess fear-related
experiences during the pandemic according to Schimmenti et al.’s
(12) theoretical model, a measure of psychopathology, and additional
instruments not directly related to the objective of the current study.
The survey was opened for 10 days, from 27 April 2020 to 5 May
2020. Of 628 total respondents, 623 completed the survey. The survey
software did not allow participants to skip any question and therefore,
there were no missing or incomplete responses in the dataset.
Measures
Sociodemographic Questionnaire
Participants were asked to provide sociodemographic information,
including gender, age, number of years of education, employment
status, and marital status during the COVID-19 pandemic.
Multidimensional Assessment of COVID-19-Related
Fears
The MAC-RF is an eight-item self-report measure scored on a
five-point Likert scale (from 0 to 4) that was developed by the
authors of this article to assess the eight facets of fear identified by
Schimmenti et al. (12). The MAC-RF was derived from a set of
16 items. Using item response theory (IRT) analysis, the eight
items that were most discriminating for each facet of fear (i.e.,
those displaying the higher a-value in the current study) were
selected and included in the final version of the instrument.
Scores of the MAC-RF can range from 0 to 32, with higher scores
indicating higher COVID-19-related fears. The MAC-RF was
developed in Italian, French, and English languages (see the
Supplementary Material), with team consensus on translation
and back-translation of its items. Findings reported in this study
concern the Italian version of the measure. The psychometric
properties of the French and English version of the MAC-RF are
still under examination, as data collection in French- and
English-speaking countries started later than in Italy, in which
lockdown measures have been taken since early March 2020. The
psychometric properties of the Italian translation of the measure
are extensively described below in the Results section.
DSM-5 Self-Rated Level 1 Cross-Cutting Symptom
Measure-Adult (CCSM)
The Cross-Cutting Symptom Measure-Adult (CCSM) is a 23-
item, self-report measure used for screening of various domains
of psychopathology. It assesses relevant clinical symptoms that
occurred in the preceding 2 weeks on a 0 to 4 Likert scale (from
“none” to “severe”). The CCSM is included in the Diagnostic and
Statistical Manual of Mental Disorders—Fifth Edition (DSM-5;
American Psychiatric Association, 2013) and provides 13 clinical
symptom domain scores (depression, anxiety, anger, mania,
somatic symptoms, suicidal ideation, psychosis, sleep problems,
memory problems, obsessive-compulsive symptoms, dissociation,
maladaptive personality functioning, and substance use). A total
score on the CCSM is obtained by averaging the scores on clinical
symptom domains. A sample item is “little interest or pleasure in
doing things” (related to the symptom domain of depression). TheJuly 2020 | Volume 11 | Article 748
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DSM field trials (16) and many studies across the world (17, 18).
Internal consistency (Cronbach’s alpha value) of the CCSM in the
current study was.89.
Statistical Analyses
To select the eight items to be retained in the final version of the
MAC-RF, the Pearson’s r correlation between the item scores
and the total score of the original sixteen items were examined.
This procedure was complemented with an exploratory use of
item response theory (IRT) analysis, and the a-parameter value
of each item was calculated. For each pair of items per fear facet,
we retained the item showing the highest correlation with the
total score of the 16 items (thus the item being more consistent
with the entire measure) and showing the highest a-value (thus
showing the highest capacity to discriminate the hypothesized
latent construct of COVID-19 related fear). Subsequently, we
tested via exploratory factor analysis if the eight selected items
would tap into a single factor. After verifying that this condition
was met, unidimensional IRT analyses based on graded model
were conducted to examine the psychometric properties of the
final eight-item version of the MAC-RF in reflecting adequately
the latent construct of COVID-19-related fears. In particular,
we considered the values of the a parameter (the larger this
value, the better the item is able to discriminate between people
with varying degrees of the latent construct q) and b parameter
(where high b values indicate a difficult item, that is, a decreased
probability that high scores on the item are endorsed). We also
examined the test information function (the amount of
information yielded by the test at any level of the dimensionally
conceptualized construct), and we assessed the goodness of fit of
the IRT model by testing exact (M2) and approximate (root mean
square error of approximation, RMSEA) fit. Nonsignificant M2
probability indicates exact fit. However, in IRT applications it is
highly unlikely that a model will exactly fit the data, thus statistics
for approximate fit are used, such as the RMSEA, that takes into
account both the M2 value and the degrees of freedom of the
model. An RMSEA below.05 indicates adequate fit, that is,
indicates that the latent trait dimensionality is correctly specified
(19). Descriptive statistics were then computed for all study
variables. Gender differences were tested through t-tests for
independent samples. Correlational analyses were performed to
examine the associations between MAC-RF scores and scores on
various domains of psychopathology.
A receiver operating characteristic curve (ROC) analysis was
conducted to further test the ability of the MAC-RF to predict the
severity of clinical symptoms in the sample, using the 75th
percentile of the CCSM total score to dichotomize between cases
and non-cases with high levels of psychopathology (20, 21). By
applying this rule of thumb, we were able to identify a cutoff value
for the CCSM that took into account the global increase in clinical
symptoms observed in the population as a response to the
COVID-19 pandemic (22). Sensitivity (the proportion of true
positive individuals with the condition in a total group of subjects
with the condition), specificity (the proportion of participantsFrontiers in Psychiatry | www.frontiersin.org 4without the condition with negative test result in the total of
participants without the condition), positive likelihood ratio (the
likelihood that positive test results occur in participants with the
condition compared to those without the condition), negative
likelihood ratio (the ratio of the probability that negative results
occur in participants with the condition to the probability that the
same result will occur in participants without the condition),
positive predictive value (the probability of having the condition
in a subject with positive results), and negative predictive value
(the probability of not having the condition in participants with
negative test result) were calculated to test the ability of the MAC-
RF to identify participants with a “condition” (i.e., those with high
levels of psychopathology).RESULTS
Item Selection, Internal Structure, and
Reliability
Item-total correlation values and a-values of an IRT analysis
based on graded model were first examined to select the single
item to retain for each of the eight fear facets of Schimmenti et
al.’s (12) theoretical model. Supplementary Table 1 displays the
original 16 items, their item-total correlation values, their a-
values, and the outcome (whether or not they were retained for
the eight-item MAC-RF). We compared the rs of item-total
correlations and the a-values of the item pairs related to each fear
facet, and then selected one item that better reflected each fear
facet. This empirically based selection of items allowed us to
include in the MAC-RF only one item for each fear facet, as per
our quality criteria.
We then performed an exploratory factor analysis on the
eight item of the MAC-RF, to test if a single-factor solution was
tenable. We used the principal axis factoring method selecting
the oblimin rotation to allow the potentially identified factors to
correlate, as per theoretical model prediction. The data were
homoscedastic [Bartlett’s c2 (28) = 1,719.29, p <.001], and the
sample size was adequate for factor analysis (Keyser-Meyer-
Olkin = .87). A single factor was extracted that explained 41.47%
of variance, with all items loading above.40 on the factor. The
examination of the eigenvalues and the scree-plot clearly
supported the single factor solution for the eight items (with
the first five eigenvalues being 3.85,.91,.84,.67, and.54).
After the positive testing for unidimensionality, we proceeded
with unidimensional IRT analysis of the final measure. The
results of IRT analysis based on graded model are summarized
in Table 2. Each item of the MAC-RF provided sufficient (item 5)
to excellent (item 2) level of information on the latent construct
of the specific fear facet. The most discriminant item (i.e., the
item with higher a-value) was item 2 (concerning a fear for the
body), while the most difficult item (i.e., the item with the highest
b-value and with the lowest probability to receive a high score)
was item 6 (related to the fear of not knowing).
With regards to the information provided by the MAC-RF at
different levels of q (in IRT analyses, q represents the latentJuly 2020 | Volume 11 | Article 748
Schimmenti et al. MAC-RFvariable that is standardized to have a mean of 0 and a standard
deviation of 1), the MAC-RF provided most information on the
latent construct of fear at levels of q between 0 and + 0.8 (Table 3).
The MAC-RF was not particularly informative at its lowest total
scores, as expected of a measure that aims to identify individuals
with clinically relevant levels of fear. With the MAC-RF total
scores of 11 (which corresponds to a q of 0 in the population-
based distribution conversion table from summed score to scale
score) or above, the instrument provided a highly relevant
information on the latent construct of each fear facet. A total
MAC-RF score of 20 corresponded to a q of 1, suggesting that this
score might be a cut-off value for identifying heightened
experiences of fear that deserve clinical attention.
Amarginal reliability for response pattern scores was .87. Table
4 shows factor loadings of the MAC-RF items. The statistics based
on one-way, two-way, and full marginal tables showed a
significant M2 (728.16, df=440, p<.001), but a satisfactory
RMSEA of.03 indicating that the latent trait dimensionality was
correctly specified in the IRT model. All eight items loaded
positively and moderately to highly on the latent construct.
Further analyses based on the classical test theory showed a
good internal consistency (Cronbach’s alpha = .84) of the MAC-
RF, satisfactory split-half reliability (Spearman-Brown r= .78),
and an average inter-item correlation of.39 (thus in the suggested
range between.20 and.40). All items of the MAC-RF were
moderately to strongly correlated with its total score (from r = .54
to r = .80, all ps<.001).
These results suggest that the MAC-RF is an informative and
reliable measure of COVID-19-related fears.Frontiers in Psychiatry | www.frontiersin.org 5Descriptive Statistics
MAC-RF total scores ranged from 0 to 30 (M=11.21, SD=7.04;
interquartile range= 6–16; skewness=.36, kurtosis=−.68). CCSM
total scores ranged from 0 to 3.51 (M=.96, SD=.62). Table 4
displays descriptive statistics for the MAC-RF and CCSM scores
for the full sample and for males and females separately.
As Table 5 shows, the fear for significant others (item 4) was
more strongly endorsed compared to all other fear facets.
Participants also reported significant levels of symptoms of
anger, depression, anxiety, mania, and sleep problems on
average (more than one or two episodes in the preceding 2
weeks). Concerning gender differences, females reported
significantly increased COVID-19-related fear experiences on
all the items of the MAC-RF except for item 6, related to the fear
of not knowing. As a result, MAC-RF total scores were also
significantly higher in females. This pattern of results on the
MAC-RF corresponds to the CCSM scores, where females
reported significantly more symptoms than males. A series of
t-tests for independent samples with Bonferroni’s correction for
multiple comparisons showed that females reported significantly
higher levels of the symptoms of depression, mania and anxiety,TABLE 3 | Item information function of the Multidimensional Assessment of COVID-19-Related Fears (MAC-RF) at different values of q (from −2.8 to 2.8).
Item Facet of fear −2.8 −2.4 −2.0 −1.6 −1.2 −0.8 −0.4 0.0 0.4 0.8 1.2 1.6 2.0 2.4 2.8
1 Fear of the body 0.04 0.07 0.15 0.29 0.51 0.77 0.97 1.06 1.09 1.09 1.09 1.05 0.94 0.72 0.46
2 Fear for the body 0.01 0.02 0.07 0.25 0.81 2.00 2.91 3.04 3.10 3.10 2.99 2.54 1.27 0.43 0.12
3 Fear of others 0.11 0.23 0.44 0.76 1.05 1.18 1.21 1.24 1.25 1.23 1.18 1.16 1.06 0.78 0.47
4 Fear for others 0.19 0.39 0.72 1.08 1.27 1.33 1.37 1.37 1.35 1.29 1.11 0.77 0.43 0.21 0.09
5 Fear of knowing 0.08 0.11 0.14 0.17 0.20 0.23 0.25 0.26 0.27 0.27 0.27 0.27 0.27 0.26 0.26
6 Fear of not knowing 0.05 0.08 0.11 0.17 0.23 0.30 0.37 0.41 0.44 0.45 0.46 0.46 0.45 0.44 0.44
7 Fear of action 0.02 0.04 0.08 0.19 0.39 0.71 1.07 1.28 1.35 1.37 1.36 1.33 1.24 1.00 0.63
8 Fear of inaction 0.10 0.14 0.19 0.25 0.30 0.34 0.37 0.39 0.39 0.39 0.39 0.38 0.37 0.36 0.32
Test information: 1.59 2.08 2.92 4.15 5.77 7.86 9.52 10.06 10.23 10.20 9.86 8.96 7.04 5.20 3.79
Expected s.e.: 0.79 0.69 0.59 0.49 0.42 0.36 0.32 0.32 0.31 0.31 0.32 0.33 0.38 0.44 0.51July 2020 | Volume 11 | ArticleTABLE 4 | Factor loadings of the Multidimensional Assessment of COVID-19-
Related Fears (MAC-RF) items.
Item Item content l s.e.
1 I don’t trust my own body to protect me against the
coronavirus infection.
0.74 0.05
2 I am frightened about my body being in contact with objects
contaminated by the coronavirus.
0.89 0.03
3 I fear that people who are around me can infect me. 0.77 0.04
4 I am frightened about my family members or close friends
being in contact with other people and becoming infected
with the coronavirus.
0.78 0.04
5 I do not want to be exposed to information about the
coronavirus infection because it makes me feel upset and
anxious.
0.48 0.07
6 I feel upset if I cannot collect all the information I need about
the coronavirus.
0.58 0.06
7 During the coronavirus pandemic I feel paralyzed by
indecisiveness or fear of doing something wrong.
0.78 0.04
8 During the coronavirus pandemic I constantly feel that I have
to do something.
0.55 0.06TABLE 2 | Multidimensional Assessment of COVID-19-Related Fears (MAC-RF)
item parameter estimates.
Item Facet of fear a b1 b2 b3 b4
1 Fear of the body 1.87 −0.37 0.43 1.15 1.89
2 Fear for the body 3.24 −0.46 0.19 0.79 1.44
3 Fear of others 2.03 −1.03 −0.05 0.78 1.86
4 Fear for others 2.11 −1.35 −0.49 0.18 1.00
5 Fear of knowing 0.93 −0.50 0.63 1.76 3.35
6 Fear of not knowing 1.20 −0.04 1.08 2.07 3.49
7 Fear of action 2.10 −0.14 0.62 1.24 2.05
8 Fear of inaction 1.11 −0.70 0.32 1.25 2.51748
Schimmenti et al. MAC-RFas well as somatic symptoms and memory problems, whereas
males reported significantly higher levels of substance use.
Association With Psychopathology and
Convergent Validity
The MAC-RF total and item scores were significantly correlated
with CCSM total scores, with the levels of associations being in
the moderate range (r = .55 for the association between MAC-RF
total scores and CCSM total scores, rs ranging from.31 to.47 for
the associations between MAC-RF item scores and CCSM total
scores, all ps <.001). Table 6 shows correlations between the
MAC-RF total and item scores and the CCSM domain scores. All
correlations between the total MAC-RF scores and CCSM
domain scores were significant, except for substance use.
MAC-RF total and item scores showed the strongest
associations with anxiety symptoms. The patterns of these
associations did not change when partial correlations were
examined and the effects of gender, age, education, and days
spent in pandemic-related restriction conditions were partialled
out. Overall, the correlational findings support the convergent
validity of the MAC-RF.
Identifying Cases With High Levels of
Current Psychopathology
Finally, we performed a ROC curve analysis to test the ability of
the MAC-RF to identify cases with high levels of current
psychopathology. The 75th percentile of the total CCSM score
(i.e., the last quartile) corresponding to scores above 1.32 was
used to delineate participants with high levels of current
psychopathology. An area under the curve was.76 (95%
C.I.72–.81, p<.001), indicating that the MAC-RF total score isFrontiers in Psychiatry | www.frontiersin.org 6sufficiently able to identify cases with high levels of current
psychopathology. Examining the potential cut-off scores of the
MAC-RF, we found that a cut-off score of 12 seemed to suggest
high levels of current psychopathology. This is based on the
sensitivity of 75.80%, specificity of 62.45%, positive likelihood
ratio of 2.02, negative likelihood ratio of 0.39, positive predictive
value of 40.48%, and negative predictive value of 88.45%. These
findings confirm the positive relationship between COVID-19-
related fears and overall psychopathology.DISCUSSION
This article examined the psychometric properties of the Italian
version of the MAC-RF, a theory-based measure that was
developed for the screening and assessment of clinically
relevant fears during the COVID-19 pandemic. Even though
the MAC-RF is not the first measure that was developed to assess
COVID-19-related fears (13, 23), it might have some theoretical
and clinical advantages over other dedicated instruments. The
advantages of a theory-based measure include interpretability of
item scores according to theory, testing the theory itself, and the
possibility to combine theory with results of the assessment to
guide clinical decision-making. Our findings suggest that the
MAC-RF adequately taps all the eight domains of fear during the
COVID-19 pandemic proposed by Schimmenti and colleagues
(12). The instrument might also have some predictive value in
identifying individuals at increased risk of current psychopathology
during the COVID-19 pandemic.
The eight items of the MAC-RF identified by IRT analysis
provided sufficient to excellent information on the latentTABLE 5 | Descriptive statistics of the Multidimensional Assessment of COVID-19-Related Fears (MAC-RF) and Cross-Cutting Symptom Measure-Adult (CCSM) and
gender differences.
Total (N = 623) Males (n = 175) Females (n = 448) t(621) p
M SD M SD M SD
MAC-RF total score 11.21 7.04 9.47 6.25 11.89 7.22 −3.91 <.001
MAC-RF item 1 1.27 1.31 0.96 1.11 1.39 1.36 −3.70 <.001
MAC-RF item 2 1.44 1.34 1.13 1.24 1.56 1.36 −3.62 <.001
MAC-RF item 3 1.65 1.23 1.45 1.16 1.72 1.25 −2.47 .014
MAC-RF item 4 2.20 1.37 1.87 1.26 2.33 1.39 −3.86 <.001
MAC-RF item 5 1.23 1.27 0.99 1.16 1.32 1.29 −2.99 .003
MAC-RF item 6 0.91 1.11 0.96 1.11 0.90 1.11 .66 .51
MAC-RF item 7 1.09 1.25 0.89 1.1 1.16 1.30 −2.45 .015
MAC-RF item 8 1.43 1.33 1.22 1.21 1.51 1.37 −2.46 .014
CCSM total score 0.96 0.62 0.85 0.58 1.00 0.63 −2.79 .005
Depression 1.64 1.07 1.42 1.07 1.73 1.06 −3.33 .001
Anger 1.91 1.20 1.78 1.24 1.96 1.19 −1.72 .085
Mania 1.32 0.99 1.20 0.93 1.37 1.01 −1.97 .050
Anxiety 1.47 1.05 1.08 0.96 1.63 1.05 −6.04 <.001
Somatic symptoms 0.90 1.03 0.71 0.92 0.97 1.07 −2.92 .004
Suicidal ideation 0.17 0.59 0.20 0.65 0.16 0.56 .71 .480
Psychosis 0.11 0.43 0.10 0.36 0.12 0.45 −.50 .621
Sleep problems 1.45 1.37 1.31 1.33 1.50 1.38 −1.54 .124
Memory problems 0.51 0.97 0.37 0.81 0.56 1.02 −2.26 .024
Obsession/compulsion 0.66 0.97 0.63 0.95 0.67 0.98 −.40 .693
Dissociation 0.57 1.00 0.45 0.89 0.62 1.03 −1.95 .052
Maladaptive personality 1.12 1.15 1.05 1.05 1.15 1.18 −1.01 .313
Substance use 0.62 0.80 0.74 0.82 0.57 0.79 2.42 .016July 2020 | Volume 11 | Article 748
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Frontiers in Psychiatry | www.frontiersin.org 7construct of fear (see Table 2), with values of the a parameter
ranging from 0.93 to 3.24. Notably, the highest value of the a
parameter was found for item 2, related to the fear for the body,
and thus to the fear of being contaminated by the virus. This
finding is consistent with research (13) and theory (24)
suggesting that the most prominent fear during the pandemics
relates to the risk of illness and death. Results of the validation
studies of the other two instruments developed to assess fear and
related constructs in the context of the COVID-19 pandemic are
also in agreement with our findings. Thus, one of the item of the
fear of COVID-19 scale on which the participants had the
highest scores assessed a fear of death resulting from COVID-
19 (13). Similarly, a factor concerning danger and contamination
fears extracted from the COVID Stress Scales accounted for most
variance compared to other factors (23). In contrast, the lowest
value of the a parameter (and thus the lowest discrimination
ability for the underlying construct of fear) was observed for item
5 of the MAC-RF which regards the fear of knowing. This result
suggests that knowledge about COVID-19 and the associated
risks is perceived as promoting a sense of control, with the fear of
not having that knowledge being most distressing.
The most difficult item (i.e., the item with the highest value
in the IRT b parameter) of the MAC-RF was the fear of not
knowing, seemingly opposite from the item concerning the fear
of knowing. This apparently paradoxical result is consistent with
the theory on COVID-19-related fears proposed by Schimmenti
et al. (12), which posits the dialectical alternation of fears of
knowing and not knowing during the pandemic. This finding
may be explained by the reluctance of many people to know “too
much” about the pandemic to avoid being overwhelmed by
frightening information.
The fit indices of the MAC-RF were good (see Table 4), with
all items loading above.45 on the latent construct and a good
RMSEA of.03 (25). Also, internal reliability was good and the
average inter-item correlations were in the suggested range
between.20 and.40 (26). Thus, the MAC-RF can be considered
an internally valid and reliable measure of the fears related to
COVID-19.
We also found gender differences, with females displaying
higher levels of fears than males on the total MAC-RF scores and
on all item scores, except for item 6 related to the fear of not
knowing (see Table 5). These gender differences were analogous
to gender differences on the general psychopathology scores,
where females reported higher levels of depression, mania,
anxiety, somatic symptoms, and memory problems than males,
while males reported higher substance use than females. These
findings are highly consistent with previous research reporting
increased levels of fear among females (27, 28), and more
generally with research showing that females are more prone
to internalizing symptoms, such as anxiety and depression,
whereas males are more prone to externalizing symptoms,
such as substance use and antisocial behaviors (29, 30).
It is worth noting that the scores on various domains of
psychopathology were quite high in our sample (see Table 5),
with mean scores of 1 or above on the specific domains of
depression, anger, mania, anxiety, sleep problems, and maladaptiveTA
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Schimmenti et al. MAC-RFpersonality functioning. This means that, on average, our
participants reported the presence of symptoms related to these
domains as occurring at least once in the 2 weeks before
completing the survey. We believe that these high scores are a
consequence of the pandemic situation. It has been suggested in
recent literature that the COVID-19 pandemic may have
profoundly negative effects on the overall functioning of
individuals by altering their habits and daily life (31), evoking
uncertainty and insecurity in the relationship between the self and
the world (1) and causing intense anxiety responses (13).
Results of correlational analyses supported the convergent
validity of the MAC-RF, whose items correlated positively and
significantly with the total score of a measure assessing different
types of psychopathological symptoms (see Table 6). This
suggests that the MAC-RF assesses clinically relevant fears
associated with a more severe current psychopathology.
Notably, the strongest correlation of the MAC-RF was observed
with anxiety, which is consistent with theory and neurobiological
evidence that fear and anxiety are highly connected and that they
overlap (2). However, the MAC-RF was positively and
significantly associated with several other psychopathological
domains, supporting a view that domains of fear assessed by the
MAC-RF are relevant for identifying overall psychopathology and
not only its anxiety domain.
We examined the ability of the MAC-RF to identify cases with
high levels of current psychopathology via a ROC curve analysis.
This analysis revealed that the MAC-RF performed sufficiently
well in this regard, with an area under the curve of.76. However,
the MAC-RF displayed an adequate sensitivity but a limited
specificity at the suggested cut-off value of 12, indicating that its
use in screening practice should be complemented with other
specific measures on psychopathology. Nonetheless, the overall
results of the ROC analysis, especially the positive likelihood
ratio of 2.02 and the negative predictive value of 88.45%, suggests
that the MAC-RF maintains some usefulness in identifying those
individuals whose COVID-19-related fear experiences are
associated with increased clinical symptoms.
The present study has several limitations. First, the MAC-RF is
based on a specific theory about different domains of fear during a
pandemic. While this is an advantage and the theory is rather
comprehensive, it is possible that some relevant domains of fears
have been overlooked by the theory and therefore, they are not
assessed by the MAC-RF. Second, the study was cross-sectional,
precluding any conclusions about possible causal relationships
between domains of fear and various aspects of psychopathology.
Longitudinal studies using the MAC-RF are needed to better
understand these relationships. Third, findings of the study were
based on self-report, which is subject to various biases. In this
context, it is noteworthy that individuals with high levels of
psychopathology have been identified using an empirically-
derived cutoff value on a self-report measure. Future studies
should test the validity of the MAC-RF against a more strict
criterion, such as the presence of a psychiatric diagnosis. Finally,
the study was conducted in Italian adults recruited online from the
general population and its findings do not necessarily generalize to
other population groups, such as adolescents, people with variousFrontiers in Psychiatry | www.frontiersin.org 8mental disorders, and individuals from a different ethnic
background. Therefore, studies in samples more clearly
representative of the general population of various countries, as
well as studies in clinical samples, are warranted.
CONCLUSIONS
Findings of the present study support use of the MAC-RF as a
brief, theory-based instrument for assessment of clinically
relevant fears related to the COVID-19 pandemic. Although
the MAC-RF was developed for use in the context of this
pandemic, it could be administered to assess fear experience in
other public health emergencies, especially future pandemics
during which the causative agent spreads rapidly via human
contact and is associated with mortality and much uncertainty.
Modifications of the MAC-RF for this purpose would be simple,
with changes in the wording of the relevant items (e.g., by
replacing the term “coronavirus” with a term related to
another pandemic situation). The MAC-RF was simultaneously
developed in three languages and its versions in Italian, English,
and French are presented in the Supplementary Material to
this article.
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